EXAS - CIK 0001124140
The table below shows EXACT SCIENCES CORP's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $491.44M | $210.54M | $156.12M | -$223.56M | -$102.24M | $136.48M |
| Capital expenditure | $134.66M | $135.99M | $124.19M | $214.46M | $135.77M | $65.08M |
| Investing cash flow | $195.12M | -$442.15M | $49.68M | $74.07M | -$1.08B | -$702.04M |
| Dividends paid | - | - | - | - | - | - |
EXACT SCIENCES CORP reported operating cash flow of $491.44M for fiscal year 2025. That is up 133.4% from $210.54M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$130.07M (FY 2016) to $491.44M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$338.09M | $231.87M | $159.77M | $76.48M | $8.47M | $1.88B |